
Bacteriostatic Water
Sterile reconstitution diluent, 3ml
From
£4

FORM Peptides clear glass vial, research use only.
For research use only. Not for human consumption.
≥98% HPLC · Lyophilised vial
Next-generation triple agonist referenced in metabolic research.
Retatrutide is a next-generation triple agonist that simultaneously targets three hormone receptors, GIP, GLP-1, and glucagon, involved in appetite regulation, blood sugar control, and fat metabolism. This triple-action mechanism is what distinguishes it from earlier generation compounds, and early phase trials have shown it to produce some of the most significant fat loss results seen in this class of research to date. It is currently progressing through Phase 3 clinical trials and represents one of the most closely watched compounds in metabolic and obesity research.
Format & strength
Pen
£200
/ vialDocuments
Reconstituting research material? An interactive vial draw calculator is available for dilution and volume equivalence.
Using the multi-use pen format? A pen draw calculator covers U-100 volume equivalence.
Complete your order by email or WhatsApp and our team will respond with payment and dispatch confirmation. We accept bank transfer and cryptocurrency, with card checkout coming soon. Reach us at info@formpeptides.co.uk or via WhatsApp.
Specification
Related compounds

Sterile reconstitution diluent, 3ml
From
£4

Modified GH fragment, 5mg vial
From
£30

Stabilised GHRH analogue, 10mg vial
From
£55
Product FAQ
Programmatic supply
Bulk and recurring research supply, custom batch documentation, and institutional invoicing are available on request.
Supplied for research purposes only. Not for human consumption. FORM Peptides does not provide dosage or consumption advice.